278 related articles for article (PubMed ID: 22257369)
1. The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice.
Vinueza Veloz MF; Buijsen RA; Willemsen R; Cupido A; Bosman LW; Koekkoek SK; Potters JW; Oostra BA; De Zeeuw CI
Genes Brain Behav; 2012 Apr; 11(3):325-31. PubMed ID: 22257369
[TBL] [Abstract][Full Text] [Related]
2. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
[TBL] [Abstract][Full Text] [Related]
3. Group I metabotropic glutamate receptor antagonists alter select behaviors in a mouse model for fragile X syndrome.
Thomas AM; Bui N; Perkins JR; Yuva-Paylor LA; Paylor R
Psychopharmacology (Berl); 2012 Jan; 219(1):47-58. PubMed ID: 21656124
[TBL] [Abstract][Full Text] [Related]
4. Fmr1 knockout mice are impaired in a leverpress escape/avoidance task.
Brennan FX; Albeck DS; Paylor R
Genes Brain Behav; 2006 Aug; 5(6):467-71. PubMed ID: 16923151
[TBL] [Abstract][Full Text] [Related]
5. Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome.
Thomas AM; Bui N; Graham D; Perkins JR; Yuva-Paylor LA; Paylor R
Behav Brain Res; 2011 Oct; 223(2):310-21. PubMed ID: 21571007
[TBL] [Abstract][Full Text] [Related]
6. Learning and memory deficits consequent to reduction of the fragile X mental retardation protein result from metabotropic glutamate receptor-mediated inhibition of cAMP signaling in Drosophila.
Kanellopoulos AK; Semelidou O; Kotini AG; Anezaki M; Skoulakis EM
J Neurosci; 2012 Sep; 32(38):13111-24. PubMed ID: 22993428
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.
Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B
Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253
[TBL] [Abstract][Full Text] [Related]
8. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome.
Osterweil EK; Krueger DD; Reinhold K; Bear MF
J Neurosci; 2010 Nov; 30(46):15616-27. PubMed ID: 21084617
[TBL] [Abstract][Full Text] [Related]
9. Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors.
Nakamoto M; Nalavadi V; Epstein MP; Narayanan U; Bassell GJ; Warren ST
Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15537-42. PubMed ID: 17881561
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.
Qin M; Zeidler Z; Moulton K; Krych L; Xia Z; Smith CB
Behav Brain Res; 2015 Sep; 291():164-171. PubMed ID: 25979787
[TBL] [Abstract][Full Text] [Related]
11. Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.
Nosyreva ED; Huber KM
J Neurophysiol; 2006 May; 95(5):3291-5. PubMed ID: 16452252
[TBL] [Abstract][Full Text] [Related]
12. Impaired cognitive discrimination and discoordination of coupled theta-gamma oscillations in Fmr1 knockout mice.
Radwan B; Dvorak D; Fenton AA
Neurobiol Dis; 2016 Apr; 88():125-38. PubMed ID: 26792400
[TBL] [Abstract][Full Text] [Related]
13. Altered structural and functional synaptic plasticity with motor skill learning in a mouse model of fragile X syndrome.
Padmashri R; Reiner BC; Suresh A; Spartz E; Dunaevsky A
J Neurosci; 2013 Dec; 33(50):19715-23. PubMed ID: 24336735
[TBL] [Abstract][Full Text] [Related]
14. Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X syndrome.
Costa L; Spatuzza M; D'Antoni S; Bonaccorso CM; Trovato C; Musumeci SA; Leopoldo M; Lacivita E; Catania MV; Ciranna L
Biol Psychiatry; 2012 Dec; 72(11):924-33. PubMed ID: 22817866
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated NMDA-Receptor Signaling Inhibits Long-Term Depression in a Mouse Model of Fragile X Syndrome.
Toft AK; Lundbye CJ; Banke TG
J Neurosci; 2016 Sep; 36(38):9817-27. PubMed ID: 27656021
[TBL] [Abstract][Full Text] [Related]
16. Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development.
Pop AS; Gomez-Mancilla B; Neri G; Willemsen R; Gasparini F
Psychopharmacology (Berl); 2014 Mar; 231(6):1217-26. PubMed ID: 24232444
[TBL] [Abstract][Full Text] [Related]
17. Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice.
de Vrij FM; Levenga J; van der Linde HC; Koekkoek SK; De Zeeuw CI; Nelson DL; Oostra BA; Willemsen R
Neurobiol Dis; 2008 Jul; 31(1):127-32. PubMed ID: 18571098
[TBL] [Abstract][Full Text] [Related]
18. Reversal of activity-mediated spine dynamics and learning impairment in a mouse model of Fragile X syndrome.
Boda B; Mendez P; Boury-Jamot B; Magara F; Muller D
Eur J Neurosci; 2014 Apr; 39(7):1130-7. PubMed ID: 24712992
[TBL] [Abstract][Full Text] [Related]
19. Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice.
Guo W; Molinaro G; Collins KA; Hays SA; Paylor R; Worley PF; Szumlinski KK; Huber KM
J Neurosci; 2016 Feb; 36(7):2131-47. PubMed ID: 26888925
[TBL] [Abstract][Full Text] [Related]
20. Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models.
Zhang J; Hou L; Klann E; Nelson DL
J Neurophysiol; 2009 May; 101(5):2572-80. PubMed ID: 19244359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
